Posted by on Mar 26, 2013 in Melanoma | 0 comments

In a nutshell This article published in 2013 reviews information from clinical studies which looked at new treatments for cutaneous melanoma.  These include drugs that aim to stimulate the body's anti-tumor immune response, such as ipilimumab (Yervoy) and tremelimumab and those that target genetic mutations in cancer cells. Some background...

Read More